This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! Online Registration Closes In:

  • 00
  • 00
  • 00
  • 00
December 4 - 8, 2022
Marriott Marquis San DiegoLive In-Person Event: December 4 - 8, 2022

December 4 - 8, 2022
Marriott Marquis San Diego,
Live In-Person Event: December 4 - 8, 2022


The latest science and research on antibody engineering, design and selection diving into critical topics including immuno-oncology, cellular engagers, miniproteins, the Fc region, cancer therapy, novel bi-specifics/multispecifics and much more!

Login Details

All login details were sent on Monday 28 November from If you have not received your login, please check your spam. If you do not receive anything by EOB Tuesday 29 November, please contact

Registered recently? You will receive your login information 48 hours after registering.

Celebrating 33 Years of Bringing The Community Together to Discuss Time-Critical Antibody Engineering Updates and Best Practices

Brand New Session Themes for 2022:

  • How to Develop an Antibody-based Drug from Discovery to IND?
  • Adaptive Immune Receptor Repertoire Data Processing, Annotation and Interpretation
  • Antibody Engineering, Libraries and Selection
  • Novel Targets for Antibody Therapeutics
  • Engineering the Fc Region to Improve Therapeutic Effects
  • Functional Screening Integrated Into Initial Antibody Discovery
  • Miniprotein Engineering
  • Strategies to Engineer Cell-based Immunotherapies

Brand New Session Themes for 2022:

  • Advances with Antibody-based Cellular Engagers
  • Remodeling the Tumor Microenvironment for Cancer Therapy
  • Novel Bispecifics, Multi-specifics and Therapeutic Combinations
  • Advancing Antibody Therapeutics in Immuno-oncology
  • Targeted Conjugates - Antibodies and Novel Platforms
  • Antibodies in Infectious Diseases
  • Progress and Challenges of Computational Approaches for Antibody Discovery and Engineering

3 Unmissable Add-On Options

Extend your learning even further with 3 vital add-on options designed to embed your knowledge prior to the main conference. 

Options include:

  • Pre-Conference Half-Day Workshop A (PM): How to Develop an Antibody-based Drug from Discovery to IND?
  • Pre-Conference Half-Day Workshop B (PM): Adaptive Immune Receptor Repertoire Data Processing, Annotation and Interpretation
  • Pre-Conference Full-Day Training Course: Introduction to Antibody Engineering

Michael Kierny, PhD

Scientist I


With fascinating presentations from high caliber speakers, the Antibody Engineering conference is essential to understanding the advances in the field.

About the Antibody Society

The Antibody Society is an international, non-profit representing individuals and organizations involved in antibody-related research and development. The Society has a variety of initiatives and working groups focused on improving the antibody field. 

We are:

  • Creating opportunities for education and networking;
  • Monitoring and reporting advances in the commercial pipeline for antibody and CAR-T therapeutics;
  • Creating standards for characterizing antibody and T-cell receptor repertoires, and engaging this field;
  • Engaging government and international agencies on matters concerning the antibody community;

 Please join us!

Put Yourself Infront Of Key Antibody Decision-Makers!

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.

Contact Kristen Schott:

Vaishali Kapoor


Washington University in St. Louis School of Medicine

Great meeting! Good learning and networking experience.